Japan’s stockmarket has been the best-performing major market so far this year. And there’s plenty more to come yet, says John Stepek.
Japan’s main stockmarket index, the Nikkei 225, has jumped above 18,700, its highest level since 2000.
Is this the year to buy biotech? Should we be investing in Europe and Japan rather than the US? And how much should a predicted rise in UK interest rates be factored into all of this? MoneyWeek’s team of experts give their opinions on the year ahead.
Voters have given Shinzo Abe the go-ahead to carry on with his plan to revitalise Japan. It may not work, but investors can certainly make a lot of money along the way. John Stepek explains how.
The FTSE 100 opened higher this morning, despite headwinds from Japan and Europe.
Japanese stocks remain a good bet despite the unexpected contraction in the country’s growth.
Japan may be officially in recession. But its prime minister and central bank really will do ‘whatever it takes’ to get its economy back on track. John Stepek explains.
Riding a wave of money printing isn’t the best reason to buy stocks, says Merryn Somerset Webb. But who are we to argue?
It’s been a tough year for the country, but an expanded QE programme and a falling oil price mean investors should stay put, says John Stepek.
Japan’s quantitative easing programme is the biggest in the world. And it just got bigger. That’s great news for Japanese stocks, says John Stepek.